In vitro and in vivo growth suppression of human papillomavirus 16-positive cervical cancer cells by e6 siRNA

Author： Yoshinouchi M. Yamada T. Kizaki M. Fen J. Koseki T. Ikeda Y. Nishihara T. Yamato K.

Publisher： Elsevier

ISSN： 1525-0016

Source： Molecular Therapy, Vol.8, Iss.5, 2003-11, pp. : 762-768

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Spotlight on Quadrivalent Human Papillomavirus(Types 6, 11, 16, 18) Recombinant Vaccine(Gardasil®) in the Prevention of PremalignantGenital Lesions, Genital Cancer, and Genital Warts in Women†

By McCormack Paul L.

BioDrugs, Vol. 25, Iss. 5, 2011-10 ,pp. : 339-343

Adis International

Access to resources Recommend Favorite

Human Papillomavirus Quadrivalent (types 6, 11, 16, 18) Recombinant Vaccine (Gardasil ® ): Profile Report

By Siddiqui M. Asif A. Perry Caroline M.

BioDrugs, Vol. 20, Iss. 5, 2006-01 ,pp. : 313-316

Adis International

Access to resources Recommend Favorite

Enhanced Gene Expression in Breast Cancer Cells in Vitro and Tumors in Vivo

By Lu H. Zhang Y. Roberts D.D. Osborne C.K. Templeton N.S.

Molecular Therapy, Vol. 6, Iss. 6, 2002-12 ,pp. : 783-792

Academic Press

Access to resources Recommend Favorite

Spotlight on Trastuzumab as Adjuvant Treatment in Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Early Breast Cancer†

By Garnock-Jones Karly P. Keating Gillian M. Scott Lesley J.

BioDrugs, Vol. 24, Iss. 3, 2010-06 ,pp. : 207-209

Adis International

Access to resources Recommend Favorite

siRNA: A New Approach to Target Neuropathic Pain

By > Sharma Gaurav

BioDrugs, Vol. 26, Iss. 6, 2012-12 ,pp. : 401-412

Adis International

Access to resources Recommend Favorite